Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$64,363,817
+$15,871,704 QoQ
Shares Held
53,662
+1.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#482
of 4,604 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Sep 30, 2025CallValue
$152,600,000
CallShares
200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aptus Capital Advisors, LLC holds $223,621,682 across 14 Drug Manufacturers - General names. LLY ranks #1 (28.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
53,662 | $64,363,817 | |
| 2 | JNJ |
Johnson & Johnson
|
201,691 | $51,223,462 | |
| 3 | ABBV |
AbbVie Inc.
|
142,030 | $35,740,429 | |
| 4 | MRK |
Merck & Co., Inc.
|
201,987 | $25,955,329 | |
| 5 | AMGN |
Amgen Inc
|
42,764 | $15,485,699 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
74,929 | $9,466,529 | |
| 7 | PFE |
Pfizer Inc
|
365,411 | $8,799,096 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
134,318 | $7,739,403 |
All Filings in LLY
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,363,817 | 53,662 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $48,492,113 | 52,722 | Shares | Other | 2026-05-11 | |
| 2025-12-31 | $60,903,195 | 56,671 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $41,807,822 | 54,794 | Shares | Sole | 2025-11-12 | |
| 2025-09-30 | $152,600,000 | 200,000 | Call | Sole | 2025-11-12 | |
| 2025-06-30 | $41,658,082 | 53,440 | Shares | Sole | 2025-08-11 | |
| 2025-06-30 | $311,812,000 | 400,000 | Call | Sole | 2025-08-11 | |
| 2025-03-31 | $40,359,743 | 48,867 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $34,106,960 | 44,180 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $31,430,492 | 35,477 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $27,430,297 | 30,297 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $19,326,860 | 24,843 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $13,608,267 | 23,345 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $12,551,653 | 23,368 | Shares | Other | 2023-11-08 | |
| 2023-06-30 | $11,487,196 | 24,494 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $10,241,127 | 29,821 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $12,614,528 | 34,481 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,904,655 | 33,724 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $8,143,036 | 25,115 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $4,323,614 | 15,098 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $3,452,197 | 12,498 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,530,921 | 10,954 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $2,311,725 | 10,072 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $1,364,533 | 7,304 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,378,916 | 8,167 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,115,478 | 7,536 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $3,632,810 | 22,127 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $2,267,655 | 16,347 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||